Proteins

Abstract Vancomycin, a glycopeptide antibiotic, is typically administered intravenously (IV) for severe Gram-positive bacterial infections. While the oral route offers...

Abstract Biopharmaceutical medicines represent one of the most dynamic sectors of the pharmaceutical industry, with therapeutic proteins forming the largest...

Abstract Surface adsorption of proteins in bulk drug product formulations and loss of protein structural integrity during manufacturing processes can...

Abstract RNA interference via small interfering RNA (siRNA) offers promising potential for treating glioblastoma (GB), the most common and aggressive...

Press Release Waukegan, IL – Pfanstiehl, a global leader in high-purity excipient manufacturing, announces the release of its High Purity Low...

Innovative Pharmaceutical Excipients: Natural Sources See the new book, edited by Jailani. S, Kuldeep Vinchurkar, Meghraj Suryawanshi, Sheetal Mane. This...

Abstract Inflammatory bowel disease (IBD) comprises chronic autoimmune disorders with significant morbidity, highlighting the need for advanced, noninvasive, targeted therapies....

Abstract The complexity of inflammatory bowel disease (IBD) and its pharmacological management has driven research to explore novel treatment options...

Abstract Protein-based drugs are prone to both physical and chemical instability in aqueous solutions. Surfactants, such as polysorbates (PS), are...

Abstract Lipid nanoparticles (LNPs) are of significant interest as delivery systems for various RNA therapeutics, not least due to their...